Eric Ward; breaking corporate hierarchies, searching for microbes, vaccine trials & purple tomatoes

About this episode

Eric Ward, co-founder of ag-biotech company AgBiome, walks Vance through both the deep science and the radical organizational philosophy behind his company before the conversation pivots into one of the show's most pointed critiques of institutional trust during the pandemic. On the science side, Ward describes AgBiome's "full stack" approach — collecting environmental microbe samples, sequencing nearly 100,000 bacterial genomes, and using that database to rapidly screen for biological crop protection molecules (their fungicide Howler) as traditional synthetic chemistry discovery runs dry. The organizational half of the conversation is the episode's real spine: AgBiome deliberately has no line managers, no fixed titles, and no top-down performance stack-ranking, instead distributing "boss" functions across an "agent" (an ombudsperson/mediator role) and a "development partner" (career-growth coach), with raises earned only through self-nomination and company-wide 360-degree feedback. Ward frames this as an explicit rejection of the same central-planning failure modes people readily recognize at the national level but tolerate inside corporations, while acknowledging the tradeoff: the system filters out high-ego, hierarchy-seeking personalities, which Ward links (via Jim Buchanan's public choice theory) to a broader human tendency to want a "parent" figure who takes responsibility off their hands. This segues directly into an unusually candid, sometimes profane critique of pandemic-era institutions — Ward argues the FDA and CDC "abrogated their responsibility" through opaque vaccine-approval timelines and a refusal to run ethically-fraught but epistemically clarifying human challenge trials, and both men dissect the contradiction of individuals being told vaccination is a "social responsibility" while simultaneously signing liability waivers making injury entirely their own problem. The episode closes on lighter territory: Ward's board role in the "Purple Tomato" — a genetically engineered, anthocyanin-boosted tomato designed to be the rare GMO crop with a direct consumer benefit rather than an agronomic one — and a warm tribute to Vance's late father-in-law figure, Tom Corey (Sigma-Aldrich CEO and son of Nobel laureates Carl and Gerty Cori), whom Vance credits with correctly predicting Bayer's acquisition strategy for Monsanto a year in advance.

“We discover microbes from the microbial communities on our planet that have useful properties... we sequenced the genomes of every one of those strains that we isolate... we're now bumping up toward about a hundred thousand of those.”

“Central planning at the national level has been proven a failure multiple times over. Why is it that every company works off of a central planning model? If that is the case, it makes zero sense.”

“The historically the US population had pretty good trust in entities like the FDA or the Centers for Disease Control... they completely abrogated their responsibility in any sort of visible way to the non-expert like me.”

Key moments

• ~10-15%: AgBiome's genome-database-driven microbial screening process and its "full stack" discovery-to-commercialization model.
• ~46-50%: The central-planning critique — "why does every company work off a central planning model?" — as the philosophical basis for AgBiome's flat structure.
• ~52-58%: Concrete mechanics of AgBiome's agent/development-partner system and the self-nomination raise process, including Vance's "bullshit jobs" framing of hierarchical corporate bloat.
• ~59-64%: Sharp critique of FDA/CDC pandemic communication and the ethics of forgoing human challenge trials, plus the vaccine liability-waiver contradiction.
• ~72-78%: Reflections on information abundance and choice paralysis (Tinder dating parallel, Legacy Interview subjects who "committed" to limited options and were happier for it).
• ~83-90%: The Purple Tomato origin story — a rare GMO engineered for direct consumer/health benefit, and USDA's regulatory-review policy shift making small-company GMO approval newly feasible.
• ~93-99%: Tribute to Tom Corey, Ward's late father-in-law and former Sigma-Aldrich CEO, who accurately predicted Bayer's Monsanto acquisition playbook.

Notable quotes

“We had tens of thousands of people dying of flu every winter, and nobody really knew what the population dynamics of that transmission was... historically the US population had pretty good trust in entities like the FDA or CDC... they completely abrogated their responsibility.”

“You must take this, it's your social responsibility, sign here 20 pages later that if anything bad happens to you, it's your ass... these two ends will never be squared.”

“Central planning at the national level has been proven a failure multiple times over. Why is it that every company works off of a central planning model?”

“It's sort of a Sisyphean challenge to try to put a crop on the market that's genetically modified that people actually like.”